Cargando…
Drosophila melanogaster: A platform for anticancer drug discovery and personalized therapies
Cancer is a complex disease whereby multiple genetic aberrations, epigenetic modifications, metabolic reprogramming, and the microenvironment contribute to the development of a tumor. In the traditional anticancer drug discovery pipeline, drug candidates are usually screened in vitro using two-dimen...
Autores principales: | Munnik, Chamoné, Xaba, Malungi P., Malindisa, Sibusiso T., Russell, Bonnie L., Sooklal, Selisha A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393232/ https://www.ncbi.nlm.nih.gov/pubmed/36003330 http://dx.doi.org/10.3389/fgene.2022.949241 |
Ejemplares similares
-
The Tumor Microenvironment Factors That Promote Resistance to Immune Checkpoint Blockade Therapy
por: Russell, Bonnie L., et al.
Publicado: (2021) -
History of the discovery of a master locus producing piRNAs: the flamenco/COM locus in Drosophila melanogaster
por: Coline, Goriaux, et al.
Publicado: (2014) -
Copper and Zinc Homeostasis: Lessons from Drosophila melanogaster
por: Navarro, Juan A., et al.
Publicado: (2017) -
Drosophila melanogaster: A Model Organism to Study Cancer
por: Mirzoyan, Zhasmine, et al.
Publicado: (2019) -
The genetic basis of adaptation to copper pollution in Drosophila melanogaster
por: Everman, Elizabeth R., et al.
Publicado: (2023)